A case of autoimmune hemolytic anemia associated with myasthenia gravis in a 33-year-old female is presented. The association of autoimmune hemolytic anemia and myasthenia gravis is a very rare event, with only eight cases reported. The known association of these two diseases is reviewed. To our knowledge, this is the first reported case in which autoimmune hemolytic anemia preceded systemic myasthenia gravis.
Autoimmune hemolytic anemia (AIHA) and myasthenia gravis (MG) are disorders in which autoimmune mechanisms are believed to be responsible for their pathogenesis. Both diseases have been reported to occur in patients with other autoimmune diseases.
However, the association of AIHA and MG is rare. As far as we know, only eight cases have been reported (1) (2) (3) (4) (5) (6) (7) (8) .
In seven of the eight previous cases, MG preceded the development of AIHA. Here we report a case in which MG developed during the remission period of AIHA.
CASE REPORT
A 33-year-old womanwas found to have anemia during her first pregnancy, which had not been relieved by the administration of iron. In December 1981, she delivered a mature baby. After delivery she developed a rapidly progressive anemia and was referred to our hospital for clinical evaluation. She had received no specific medication except for oral iron and antacids. She had no significant past history or family history. positive. Anti-acetylcholine receptor antibody levels were measured at 308 pmol/ml (N; < 0.6 pmol/ml). Thyroid function was normal and antithyroglobulin and antimicrosome antibodies were negative. Urinalysis showed no proteinuria and the sediment was normal. Electromyogram of hypothenar muscles by repetitive stimulation at low frequency (5 Hz) disclosed a 26.9% decrement between the first and the fifth potential.
Chest X-rays showed no evidence of thymoma.
MGwas diagnosed and the patient was given 15 mg/day of ambenonium chloride, resulting in symptomatic improvement. In July 1986, she underwent thymectomy. The thymus weighed 25 g and the histologic specimens showed hyperplasia with germinal centers (Fig. 1) . Postoperatively, the patient showed improvement in muscle strength and antiacetylcholine receptor antibody levels fell to 127 pmol/ml. The decremental response by repetitive nerve stimulation also fell to 14.0% on electromyogram. AIHA was controlled well and platelet count returned to the normal range. She was discharged, receiving 10 mg/day of prednisolone and 15 mg of ambenonium chloride.
At the 3-yr follow-up evaluation in July 1989, the patient remained well on maintenance therapy with 7.5 mg/day of prednisolone alone. WBC 5,200//;l, and the reticulocyte count was 3.0%. There has been no recurrence of MG.
DISCUSSION
In our review of the literature, there have been only eight reported cases of coexisting AIHA and MG (1-8). We analyzed the reports of the nine cases, including the present case. The ages of these patients ranged from 25 to 62 yr, six of them were female and three were male. In seven of the eight previous cases, the onset of MG preceded the onset ofAIHA by 2 months to 34 yr. In our case, AIHA preceded MG by 5 yr. AIHA preceded MG in another previous case, in which MG was the ocular type, the anti-acetylcholine receptor antibody was not increased, and the interval between the diseases was 3 yr (7). Microscopic descriptions of the thymus were available in seven cases (either by thymectomy or at autopsy), one of which showed thymoma, three disclosed hyperplasia with germinal centers, and the remaining three were normal.
It is of interest to note that AIHA developed after thymectomy for MG in three of the eight cases. 
